1. Home
  2. HLNE vs GKOS Comparison

HLNE vs GKOS Comparison

Compare HLNE & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HLNE
  • GKOS
  • Stock Information
  • Founded
  • HLNE 1991
  • GKOS 1998
  • Country
  • HLNE United States
  • GKOS United States
  • Employees
  • HLNE N/A
  • GKOS N/A
  • Industry
  • HLNE Investment Managers
  • GKOS Medical/Dental Instruments
  • Sector
  • HLNE Finance
  • GKOS Health Care
  • Exchange
  • HLNE Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • HLNE 6.2B
  • GKOS 5.5B
  • IPO Year
  • HLNE 2017
  • GKOS 2015
  • Fundamental
  • Price
  • HLNE $136.69
  • GKOS $100.14
  • Analyst Decision
  • HLNE Hold
  • GKOS Strong Buy
  • Analyst Count
  • HLNE 6
  • GKOS 13
  • Target Price
  • HLNE $160.67
  • GKOS $135.15
  • AVG Volume (30 Days)
  • HLNE 792.2K
  • GKOS 909.8K
  • Earning Date
  • HLNE 08-05-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • HLNE 1.59%
  • GKOS N/A
  • EPS Growth
  • HLNE 46.35
  • GKOS N/A
  • EPS
  • HLNE 5.41
  • GKOS N/A
  • Revenue
  • HLNE $712,963,000.00
  • GKOS $404,523,000.00
  • Revenue This Year
  • HLNE $0.05
  • GKOS $27.88
  • Revenue Next Year
  • HLNE $17.78
  • GKOS $27.60
  • P/E Ratio
  • HLNE $25.10
  • GKOS N/A
  • Revenue Growth
  • HLNE 28.73
  • GKOS 23.92
  • 52 Week Low
  • HLNE $115.52
  • GKOS $77.10
  • 52 Week High
  • HLNE $203.72
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • HLNE 31.70
  • GKOS 58.49
  • Support Level
  • HLNE $132.94
  • GKOS $97.54
  • Resistance Level
  • HLNE $139.20
  • GKOS $102.82
  • Average True Range (ATR)
  • HLNE 4.23
  • GKOS 3.51
  • MACD
  • HLNE -1.98
  • GKOS 0.67
  • Stochastic Oscillator
  • HLNE 17.53
  • GKOS 77.52

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: